Leader : Frédéric Relaix, Ph.D., DR2 INSERM
Our team, created in september 2006 is supported by the Inserm Avenir Program. We are interested in the molecular and cellular mechanisms of muscle cells specification using mouse models, and in the function of the transcription factors Pax3 and Pax7 in these processes, as well as during developpement and oncogenesis.
Team organization :
- Frédéric Relaix, Ph.D. DR2 INSERM Avenir team leader
- Aflalo-Rattenbach, Révital, Ph.D. Post-doc
- Alonso-Martin, Sonia , Ph.D., Post-doc
- Bismuth, Keren, Ph.D., Post-doc
- Masdeu, Christelle, Ph.D., Post-doc
- Rochat, Anne, Ph.D., Post-doc
Main collaborations :
- Dr Peter Zammit, King’s College, London, UK
- Dr Olivier Delattre, Institut Curie, Paris
Financial supports :
Programme Avenir INSERM, AFM, ANR, ARC, INCa.
